OTC Markets OTCPK - Delayed Quote USD
Enzolytics, Inc. (ENZC)
At close: 3:58 PM EST
Breakdown
TTM
Total Revenue
46.0790
Operating Expense
1,922.6470
Operating Income
-1,876.5680
Net Non Operating Interest Income Expense
-69.4980
Other Income Expense
-1,277.6940
Pretax Income
-6,515.9750
Net Income Common Stockholders
-6,515.9750
Diluted NI Available to Com Stockholders
-6,515.9750
Basic EPS
-300.00
Diluted EPS
-300.00
Basic Average Shares
30.1800
Diluted Average Shares
30.1800
Total Operating Income as Reported
-1,876.5680
Total Expenses
1,922.6470
Net Income from Continuing & Discontinued Operation
-6,515.9750
Normalized Income
-5,238.2810
Interest Expense
69.4980
Net Interest Income
-69.4980
EBIT
-6,446.4770
EBITDA
-6,434.1020
Reconciled Depreciation
12.3750
Net Income from Continuing Operation Net Minority Interest
-6,515.9750
Total Unusual Items Excluding Goodwill
-1,277.6940
Total Unusual Items
-1,277.6940
Normalized EBITDA
-5,156.4080
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HALB Halberd Corporation
0.0037
+27.59%
RGBP Regen BioPharma, Inc.
0.0875
+9.38%
BRTX BioRestorative Therapies, Inc.
1.4800
+3.50%
CYDY CytoDyn Inc.
0.1150
-1.88%
SPRC SciSparc Ltd.
0.2453
-14.29%
TXTM ProText Mobility, Inc.
0.0013
0.00%
RLFTF Relief Therapeutics Holding SA
5.55
0.00%
MTNB Matinas BioPharma Holdings, Inc.
0.6159
+6.21%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.9000
-0.85%
PPBT Purple Biotech Ltd
2.1900
-13.78%